NFKB1 and renal fibrosis: In doxorubicin-induced renal fibrosis models, BBR reduces collagen deposition and apoptosis by inhibiting the NF-κB/TGF-β1 signaling pathway and increasing antioxidant enzymes’ efficacy, including SOD and CAT (Ibrahim Fouad and Ahmed, 2021).